OGT’s v3 Array Improves Reporting Rate for Intragenic Deletions
A paper published in npj Genomic Medicine demonstrates the identification of more reportable CNVs with OGT’s CytoSure v3 versus traditional array design.
Read MorePosted by Melanie Hamilton-Basich | Jul 28, 2020 | Molecular Diagnostics |
A paper published in npj Genomic Medicine demonstrates the identification of more reportable CNVs with OGT’s CytoSure v3 versus traditional array design.
Read MorePosted by Melanie Hamilton-Basich | Jul 28, 2020 | Covid 19, Diagnostic Technologies |
An ultrasensitive biosensing method could dramatically shorten the amount of time required to verify the presence of the covid-19 virus in a sample.
Read MorePosted by Melanie Hamilton-Basich | Jul 25, 2020 | Covid 19, Uncategorized |
Enzo Biochem and CPESN NY are partnering to provide covid-19 testing at 52 of the network’s 155 pharmacies across the state of New York.
Read MorePosted by Melanie Hamilton-Basich | Jul 25, 2020 | Covid 19, Uncategorized |
In a meta-analysis, sputum was found to be more accurate than nasopharyngeal or oropharyngeal swabs for detecting covid-19.
Read MorePosted by Melanie Hamilton-Basich | Jul 25, 2020 | Covid 19, Uncategorized |
FDA reissued the LabCorp COVID-19 RT-PCR Test EUA to include new indications for use: for pooled sample testing and testing for asymptomatic people.
Read More